U.S. Markets close in 5 hrs 18 mins

Pfizer Inc. (PFE)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
35.49-0.02 (-0.06%)
As of 10:42AM EDT. Market open.
People also watch
MRKJNJJPMINTCGE
Full screen
Previous Close35.51
Open35.51
Bid35.46 x 3100
Ask35.47 x 1000
Day's Range35.37 - 35.65
52 Week Range29.83 - 36.21
Volume3,127,079
Avg. Volume16,973,851
Market Cap211.07B
Beta1.06
PE Ratio (TTM)25.96
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.28 (3.61%)
Ex-Dividend Date2017-08-02
1y Target EstN/A
Trade prices are not sourced from all markets
  • American City Business Journals22 hours ago

    Pfizer helps pump $103M into startup to develop new cancer therapies

    A local startup has been spun-out of Pfizer to develop clinical-stage experimental therapies. Nascent medicine company SpringWorks Therapeutics completed a $103 million series A round led by the New York-based pharma giant with the help of Bain Capital, OrbiMed and LifeArc (formerly known as MRC Technology). Pfizer (PFE) granted SpringWorks the rights to help develop four drugs or therapies that treat various conditions, including post-traumatic stress disorder and cancer.

  • Pfizer Channels Its Inner Biotech
    Bloombergyesterday

    Pfizer Channels Its Inner Biotech

    Four pipeline castoffs should fetch a higher valuation standing alone.

  • Financial Timesyesterday

    [$$] Pfizer tests new way of putting more drugs on trial

    Pfizer has backed a new drug development company with the task of shepherding four of its experimental medicines through clinical trials, in an unusual deal designed to prevent promising products from ...